These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15589001)

  • 1. Clinical characteristics of persistent lone atrial fibrillation in the RACE study.
    Rienstra M; Hagens VE; Van Veldhuisen DJ; Bosker HA; Tijssen JG; Kamp O; Bouma J; Veeger NJ; Crijns HJ; Van Gelder IC;
    Am J Cardiol; 2004 Dec; 94(12):1486-90. PubMed ID: 15589001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of rate or rhythm control on quality of life in persistent atrial fibrillation. Results from the Rate Control Versus Electrical Cardioversion (RACE) Study.
    Hagens VE; Ranchor AV; Van Sonderen E; Bosker HA; Kamp O; Tijssen JG; Kingma JH; Crijns HJ; Van Gelder IC;
    J Am Coll Cardiol; 2004 Jan; 43(2):241-7. PubMed ID: 14736444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gender-related differences in rhythm control treatment in persistent atrial fibrillation: data of the Rate Control Versus Electrical Cardioversion (RACE) study.
    Rienstra M; Van Veldhuisen DJ; Hagens VE; Ranchor AV; Veeger NJ; Crijns HJ; Van Gelder IC;
    J Am Coll Cardiol; 2005 Oct; 46(7):1298-306. PubMed ID: 16198847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rate control versus rhythm control for patients with persistent atrial fibrillation with mild to moderate heart failure: results from the RAte Control versus Electrical cardioversion (RACE) study.
    Hagens VE; Crijns HJ; Van Veldhuisen DJ; Van Den Berg MP; Rienstra M; Ranchor AV; Bosker HA; Kamp O; Tijssen JG; Veeger NJ; Van Gelder IC;
    Am Heart J; 2005 Jun; 149(6):1106-11. PubMed ID: 15976795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The RACE study in perspective of randomized studies on management of persistent atrial fibrillation.
    Hagens VE; Van Gelder IC; Crijns HJ;
    Card Electrophysiol Rev; 2003 Jun; 7(2):118-21. PubMed ID: 14618033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asymptomatic persistent atrial fibrillation and outcome: results of the RACE study.
    Rienstra M; Vermond RA; Crijns HJ; Tijssen JG; Van Gelder IC;
    Heart Rhythm; 2014 Jun; 11(6):939-45. PubMed ID: 24632222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 12-year follow-up study of patients with newly diagnosed lone atrial fibrillation: implications of arrhythmia progression on prognosis: the Belgrade Atrial Fibrillation study.
    Potpara TS; Stankovic GR; Beleslin BD; Polovina MM; Marinkovic JM; Ostojic MC; Lip GYH
    Chest; 2012 Feb; 141(2):339-347. PubMed ID: 21622553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced cardiovascular morbidity and mortality during rhythm control treatment in persistent atrial fibrillation in hypertensives: data of the RACE study.
    Rienstra M; Van Veldhuisen DJ; Crijns HJ; Van Gelder IC;
    Eur Heart J; 2007 Mar; 28(6):741-51. PubMed ID: 17272359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of prevention of heart failure by serial electrical cardioversion in patients with persistent atrial fibrillation.
    Tuinenburg AE; Van Gelder IC; Van Den Berg MP; Brügemann J; De Kam PJ; Crijns HJ
    Heart; 1999 Oct; 82(4):486-93. PubMed ID: 10490566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Verapamil versus digoxin and acute versus routine serial cardioversion for the improvement of rhythm control for persistent atrial fibrillation.
    Hemels ME; Van Noord T; Crijns HJ; Van Veldhuisen DJ; Veeger NJ; Bosker HA; Wiesfeld AC; Van den Berg MP; Ranchor AV; Van Gelder IC
    J Am Coll Cardiol; 2006 Sep; 48(5):1001-9. PubMed ID: 16949494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: the results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) Study.
    Opolski G; Torbicki A; Kosior DA; Szulc M; Wozakowska-Kaplon B; Kolodziej P; Achremczyk P;
    Chest; 2004 Aug; 126(2):476-86. PubMed ID: 15302734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does intensity of rate control influence outcome in persistent atrial fibrillation? Data of the RACE study.
    Groenveld HF; Crijns HJ; Rienstra M; Van den Berg MP; Van Veldhuisen DJ; Van Gelder IC;
    Am Heart J; 2009 Nov; 158(5):785-91. PubMed ID: 19853699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rhythm control versus rate control in patients with persistent atrial fibrillation. Results of the HOT CAFE Polish Study.
    Opolski G; Torbicki A; Kosior D; Szulc M; Zawadzka M; Pierścińska M; Kołodziej P; Stopiński M; Wozakowska-Kapłon B; Achremczyk P; Rabczenko D
    Kardiol Pol; 2003 Jul; 59(7):1-16; discussion 15-16. PubMed ID: 14560344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Atrial fibrillation: always cardioversion? No].
    Di Pasquale G; Biancoli S; Sassone B; Pancaldi LG
    Ital Heart J Suppl; 2002 Jan; 3(1):81-90. PubMed ID: 11899578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted pharmacological reversal of electrical remodeling after cardioversion--rationale and design of the Flecainide Short-Long (Flec-SL) trial.
    Kirchhof P; Fetsch T; Hanrath P; Meinertz T; Steinbeck G; Lehmacher W; Breithardt G
    Am Heart J; 2005 Nov; 150(5):899. PubMed ID: 16290956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular Events of Electrical Cardioversion Under Optimal Anticoagulation in Atrial Fibrillation: The Multicenter Analysis.
    Shin DG; Cho I; Hartaigh Bó; Mun HS; Lee HY; Hwang ES; Park JK; Uhm JS; Pak HN; Lee MH; Joung B
    Yonsei Med J; 2015 Nov; 56(6):1552-8. PubMed ID: 26446636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation.
    Van Gelder IC; Hagens VE; Bosker HA; Kingma JH; Kamp O; Kingma T; Said SA; Darmanata JI; Timmermans AJ; Tijssen JG; Crijns HJ;
    N Engl J Med; 2002 Dec; 347(23):1834-40. PubMed ID: 12466507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current management of symptomatic atrial fibrillation.
    Haghi D; Schumacher B
    Am J Cardiovasc Drugs; 2001; 1(2):127-39. PubMed ID: 14728042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted therapy of underlying conditions improves quality of life in patients with persistent atrial fibrillation: results of the RACE 3 study.
    De With RR; Rienstra M; Smit MD; Weijs B; Zwartkruis VW; Hobbelt AH; Alings M; Tijssen JGP; Brügemann J; Geelhoed B; Hillege HL; Tukkie R; Hemels ME; Tieleman RG; Ranchor AV; Van Veldhuisen DJ; Crijns HJGM; Van Gelder IC
    Europace; 2019 Apr; 21(4):563-571. PubMed ID: 30629160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study.
    Carlsson J; Miketic S; Windeler J; Cuneo A; Haun S; Micus S; Walter S; Tebbe U;
    J Am Coll Cardiol; 2003 May; 41(10):1690-6. PubMed ID: 12767648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.